Skip to main content
TipRanks
Go Ultimate75% OFF

Chong Kun Dang Pharmaceutical Corp. (185750) Income Statement

1 Followers

Chong Kun Dang Pharmaceutical Corp. Income Statement

Last quarter (Q2 2026), Chong Kun Dang Pharmaceutical Corp.'s total revenue was ₩478.47B, an increase of 10.03% from the same quarter last year. In Q2, Chong Kun Dang Pharmaceutical Corp.'s net income was ₩19.99B. See Chong Kun Dang Pharmaceutical Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
₩ 1.69T₩ 1.59T₩ 1.67T₩ 1.49T₩ 1.34T
₩ 517.23B₩ 532.61B₩ 662.20B₩ 542.64B₩ 495.82B
₩ 436.56B₩ 433.15B₩ 415.60B₩ 432.73B₩ 401.06B
Depreciation and Amortization₩ 44.69B₩ 39.77B₩ 37.03B₩ 33.60B₩ 27.48B
₩ 125.37B₩ 150.10B₩ 287.62B₩ 137.61B₩ 112.71B
₩ 80.57B₩ 99.46B₩ 246.60B₩ 109.91B₩ 94.76B
₩ 1.08B₩ 2.55B₩ -5.00B₩ -12.74B₩ -14.16B
₩ 81.65B₩ 102.01B₩ 241.60B₩ 97.17B₩ 80.59B
₩ 77.83B₩ 109.07B₩ 212.52B₩ 80.95B₩ 42.72B
Per Share Metrics
Basic EPS₩ 5882.09₩ 8206.52₩ 16704.00₩ 6608.77₩ 3117.59
Diluted EPS₩ 5845.54₩ 8206.52₩ 16704.00₩ 6608.77₩ 3117.59
Weighted Average Shares Outstanding13.18M13.25M12.72M12.25M12.44M
Weighted Average Shares Outstanding (Diluted)13.18M13.25M12.72M12.25M12.44M

Currency in KRW

Chong Kun Dang Pharmaceutical Corp. Earnings and Revenue History

0600B1.2T1.8T0 %5 %10 %15 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin